The prevalence and burden of systemic lupus erythematosus in a medicare population: retrospective analysis of medicare claims

被引:0
作者
Cindy Garris
Manan Shah
Eileen Farrelly
机构
[1] GlaxoSmithKline,
[2] Research Triangle Park,undefined
[3] Bristol-Myers Squibb,undefined
[4] Xcenda,undefined
来源
Cost Effectiveness and Resource Allocation | / 13卷
关键词
SLE; Lupus; Medicare; Disability; Burden of illness; Cost; Healthcare resource utilization;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 136 条
[1]  
Lau CS(2009)The socioeconomic burden of SLE Nat Rev Rheumatol 5 400-404
[2]  
Mak A(2005)Epidemiology of systemic lupus erythematosus in rural Wisconsin Lupus 14 862-6
[3]  
Naleway AL(1999)Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992 Arthritis Rheum 42 46-50
[4]  
Davis ME(2001)Investigation of systemic lupus erythematosus in Nogales, Arizona Am J Epidemiol 154 1029-36
[5]  
Greenlee RT(2008)Understanding the epidemiology and progression of systemic lupus erythematosus Semin Arthritis Rheum 39 257-268
[6]  
Wilson DA(2009)Renal disease in systemic lupus erythematosus with emphasis on classification of lupus glomerulonephritis: advances and implications Arch Pathol Lab Med 133 233-248
[7]  
McCarty DJ(2007)Systemic lupus erythematosus Lancet 369 587-596
[8]  
Uramoto KM(2010)Neurolupus Pract Neurol 10 4-15
[9]  
Michet CJ(2009)Thrombosis in systemic lupus erythematosus Semin Throm Hemost 35 621-629
[10]  
Thumboo J(2010)Management of cardiovascular complications in systemic lupus erythematosus Int J Clin Rheumatol 5 75-100